PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
BOSTON, March 17, 2011 /PRNewswire/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address best-practice strategic partnership models to increase operating efficiency and improve development effectiveness during the 20th Annual Partnerships in Clinical Trials conference, to be held March 30-April 1, 2011 in Phoenix, Arizona. Attendees can learn more about how PAREXEL has transformed its business to deliver a new level of strategic partnering, based on program design expertise, operational excellence, and project leadership to help clients achieve their development goals by visiting PAREXEL Booth #707 in the exhibit hall.
In two special presentations with Merck and Bristol-Myers Squibb, PAREXEL will discuss leveraging global resources and a worldwide technology infrastructure, as well as innovative approaches, to achieve significant value creation through strategic relationships:
eClinical Technology Track, March 31, 2:15 p.m.
The Evolution of CROs—Convergence of Service and Technology Providers will be presented by Mark A. Goldberg, M.D., Chief Operating Officer, PAREXEL with Lynne Germscheid, Account Management, Clinical and Regulatory Operations, Merck Research Laboratories Information Technology.
Strategic Sourcing Track, April 1, 11:00 a.m.
Committing to Two Partners—A Look at the BMS Integrated Strategic Sourcing Initiative will feature Joshua Schultz, Corporate Vice President and Strategic Account Leader, PAREXEL with Joan Millsaps, Director, Business Operations and Outsourcing Management and Cynthia Hauck, Associate Director, Outsourcing Management of Bristol-Myers Squibb.
The Partnerships in Clinical Trials pr